Assembly Biosciences, Inc.

Direct answer

Assembly Biosciences, Inc. is publicly traded on NASDAQ under the ticker ASMB.

Assembly Biosciences, Inc. is a biotechnology firm in the clinical development phase, dedicated to identifying and advancing innovative therapeutic solutions for hepatitis B virus (HBV) infections within the United States. Its primary drug candidate, Vebicorvir, has successfully concluded Phase 2 clinical trials for individuals with chronic HBV. The company's development pipeline also features ABI-H3733, which has...

Can you invest in Assembly Biosciences, Inc.?

Yes. Assembly Biosciences, Inc. trades publicly on NASDAQ as ASMB.

View deeper analysis

View detailed research on MarketSnap, including financials, valuation tools, and analyst context.

Open research for Assembly Biosciences, Inc.

Detailed equity research is provided by MarketSnap.